Genetically modified T cells delivered directly to mesothelioma cancer cells could be the key to fighting the disease, according to researchers from the Children’s Hospital of Philadelphia. According to the hospital, 27 of 30 children with recurring leukemia went into remission after modified T cells were reintroduced into their systems.
According to doctors, the T cells immediately identify other cancer cells and attack the mesothelioma, which is considered to be a particularly resilient form of cancer. As many as 3,000 Americans are diagnosed with mesothelioma every year, often due to asbestos exposure while at work.
Thousands of former employees have filed asbestos exposure lawsuits against their employers after developing mesothelioma cancer and asbestosis due to workplace exposure. Companies face hundreds of thousands of asbestos lawsuits alleging that they knowingly exposed their employees to potentially deadly asbestos fibers.